News|Articles|June 5, 2026
5 Hepatology Headlines You Missed in May 2026
Author(s)Abigail Brooks, MA
Fact checked by: Victoria Johnson
From hepatitis D's first FDA-approved therapy to advances in hepatitis B and PBC, May delivered major developments in hepatology.
Advertisement
Advertisement
May was a landmark month in hepatology, bringing major regulatory milestones, promising late-stage clinical data, and continued innovation in the diagnosis and management of chronic liver diseases. From historic progress in viral hepatitis to advances in cholestatic liver disease and emerging diagnostic technologies, the month underscored the rapid evolution of care across the specialty.
Advertisement
Advertisement
